Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin

The membrane-bound serine proteases prostasin and matriptase and the Kunitz-type protease inhibitors HAI-1 and HAI-2 are all expressed in human skin and may form a tightly regulated proteolysis network, contributing to skin pathophysiology. Evidence from other systems, however, suggests that the relationship between matriptase and prostasin and between the proteases and the inhibitors can be context-dependent. In this study the in vivo zymogen activation and protease inhibition status of matriptase and prostasin were investigated in the human skin. Immunohistochemistry detected high levels of activated prostasin in the granular layer, but only low levels of activated matriptase restricted to the basal layer. Immunoblot analysis of foreskin lysates confirmed this in vivo zymogen activation status and further revealed that HAI-1 but not HAI-2 is the prominent inhibitor for prostasin and matriptase in skin. The zymogen activation status and location of the proteases does not support a close functional relation between matriptase and prostasin in the human skin. The limited role for HAI-2 in the inhibition of matriptase and prostasin is the result of its primarily intracellular localization in basal and spinous layer keratinocytes, which probably prevents the Kunitz inhibitor from interacting with active prostasin or matriptase. In contrast, the cell surface expression of HAI-1 in all viable epidermal layers renders it an effective regulator for matriptase and prostasin. Collectively, our study suggests the importance of tissue distribution and subcellular localization in the functional relationship between proteases and protease inhibitors.

[1]  Michael D. Johnson,et al.  Selective Inhibition of Prostasin in Human Enterocytes by the Integral Membrane Kunitz-Type Serine Protease Inhibitor HAI-2 , 2017, PloS one.

[2]  Shih-Ming Huang,et al.  Natural Endogenous Human Matriptase and Prostasin Undergo Zymogen Activation via Independent Mechanisms in an Uncoupled Manner , 2016, PloS one.

[3]  Michael D. Johnson,et al.  Matriptase and prostasin are expressed in human skin in an inverse trend over the course of differentiation and are targeted to different regions of the plasma membrane , 2016, Biology Open.

[4]  T. Bugge,et al.  Delineation of proteolytic and non-proteolytic functions of the membrane-anchored serine protease prostasin , 2016, Development.

[5]  Michael D. Johnson,et al.  Plasminogen-Dependent Matriptase Activation Accelerates Plasmin Generation by Differentiating Primary Human Keratinocytes. , 2016, Journal of Investigative Dermatology.

[6]  Michael D. Johnson,et al.  Matriptase Complexes and Prostasin Complexes with HAI-1 and HAI-2 in Human Milk: Significant Proteolysis in Lactation , 2016, PloS one.

[7]  T. Bugge,et al.  Distinct Developmental Functions of Prostasin (CAP1/PRSS8) Zymogen and Activated Prostasin* , 2015, The Journal of Biological Chemistry.

[8]  Michael D. Johnson,et al.  N-Glycan Branching Affects the Subcellular Distribution of and Inhibition of Matriptase by HAI-2/Placental Bikunin , 2015, PloS one.

[9]  Michael D. Johnson,et al.  Differential Subcellular Localization Renders HAI-2 a Matriptase Inhibitor in Breast Cancer Cells but Not in Mammary Epithelial Cells , 2015, PloS one.

[10]  V. Zoete,et al.  The CAP1/Prss8 catalytic triad is not involved in PAR2 activation and protease nexin‐1 (PN‐1) inhibition , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  R. Hughey,et al.  Prostasin interacts with the epithelial Na+ channel and facilitates cleavage of the γ-subunit by a second protease. , 2014, American journal of physiology. Renal physiology.

[12]  Michael D. Johnson,et al.  Matriptase Autoactivation Is Tightly Regulated by the Cellular Chemical Environments , 2014, PloS one.

[13]  Y. Hu,et al.  Human Cancer Cells Retain Modest Levels of Enzymatically Active Matriptase Only in Extracellular Milieu following Induction of Zymogen Activation , 2014, PloS one.

[14]  Michael D. Johnson,et al.  Matriptase Expression and Zymogen Activation in Human Pilosebaceous Unit , 2014, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[15]  Michael D. Johnson,et al.  Matriptase regulates proliferation and early, but not terminal, differentiation of human keratinocytes , 2013, The Journal of investigative dermatology.

[16]  Chen-Yong Lin,et al.  A Matriptase-Prostasin Reciprocal Zymogen Activation Complex with Unique Features , 2013, The Journal of Biological Chemistry.

[17]  Michael D. Johnson,et al.  Increased matriptase zymogen activation in inflammatory skin disorders. , 2011, American journal of physiology. Cell physiology.

[18]  Michael D. Johnson,et al.  Regulation of the Matriptase-Prostasin Cell Surface Proteolytic Cascade by Hepatocyte Growth Factor Activator Inhibitor-1 during Epidermal Differentiation* , 2010, The Journal of Biological Chemistry.

[19]  KyungMann Kim,et al.  TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells. , 2010, The American journal of pathology.

[20]  J. Kao,et al.  Matriptase Activation, an Early Cellular Response to Acidosis* , 2009, The Journal of Biological Chemistry.

[21]  Michael D. Johnson,et al.  Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition. , 2009, American journal of physiology. Cell physiology.

[22]  J. P. Hobson,et al.  Potent Inhibition and Global Co-localization Implicate the Transmembrane Kunitz-type Serine Protease Inhibitor Hepatocyte Growth Factor Activator Inhibitor-2 in the Regulation of Epithelial Matriptase Activity* , 2008, Journal of Biological Chemistry.

[23]  J. P. Hobson,et al.  Co‐localization of the channel activating protease prostasin/(CAP1/PRSS8) with its candidate activator, matriptase , 2007, Journal of cellular physiology.

[24]  R. Dickson,et al.  Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain. , 2007, American journal of physiology. Cell physiology.

[25]  Chen-Yong Lin,et al.  Evidence for a Matriptase-Prostasin Proteolytic Cascade Regulating Terminal Epidermal Differentiation* , 2006, Journal of Biological Chemistry.

[26]  Thomas D. Wu,et al.  Identification of Hepatocyte Growth Factor Activator Inhibitor-1B as a Potential Physiological Inhibitor of Prostasin* , 2005, Journal of Biological Chemistry.

[27]  K. Sandhoff,et al.  The epidermal barrier function is dependent on the serine protease CAP1/Prss8 , 2005, The Journal of cell biology.

[28]  Wei Li,et al.  Tissue Expression, Protease Specificity, and Kunitz Domain Functions of Hepatocyte Growth Factor Activator Inhibitor-1B (HAI-1B), a New Splice Variant of HAI-1* , 2003, Journal of Biological Chemistry.

[29]  R. Dickson,et al.  The Activation of Matriptase Requires Its Noncatalytic Domains, Serine Protease Domain, and Its Cognate Inhibitor* , 2003, Journal of Biological Chemistry.

[30]  S. Wahl,et al.  Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis , 2002, Oncogene.

[31]  L. Chao,et al.  Prostasin Is a Glycosylphosphatidylinositol-anchored Active Serine Protease* , 2001, The Journal of Biological Chemistry.

[32]  R. Dickson,et al.  Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor. , 2001, European journal of biochemistry.

[33]  C. Craik,et al.  Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Johnson,et al.  Molecular Cloning of cDNA for Matriptase, a Matrix-degrading Serine Protease with Trypsin-like Activity* , 1999, The Journal of Biological Chemistry.

[35]  M. Johnson,et al.  Purification and Characterization of a Complex Containing Matriptase and a Kunitz-type Serine Protease Inhibitor from Human Milk* , 1999, The Journal of Biological Chemistry.

[36]  R. Schwartz,et al.  Cloning and chromosomal mapping of a gene isolated from thymic stromal cells encoding a new mouse type II membrane serine protease, epithin, containing four LDL receptor modules and two CUB domains , 1999, Immunogenetics.

[37]  R. Dickson,et al.  Characterization of a Novel, Membrane-bound, 80-kDa Matrix-degrading Protease from Human Breast Cancer Cells , 1997, The Journal of Biological Chemistry.

[38]  Lee Chao,et al.  Molecular Cloning, Tissue-specific Expression, and Cellular Localization of Human Prostasin mRNA (*) , 1995, The Journal of Biological Chemistry.

[39]  L. Chao,et al.  Prostasin is a novel human serine proteinase from seminal fluid. Purification, tissue distribution, and localization in prostate gland. , 1994, The Journal of biological chemistry.

[40]  M. Stampfer,et al.  Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[41]  V. Zoete,et al.  Title : The CAP 1 / Prss 8 catalytic triad is not involved in PAR 2 activation and protease nexin-1 ( PN-1 ) inhibition , 2022 .